Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway

Neurology

Volumn 46, Issue 2, 1996, Pages 406-412

  Lippa, C F ^a,k   Saunders, A M ^h   Smith, T W ^a   Swearer, J M ^a   Drachman, D A ^a   Ghetti, B ^b   Nee, L ^d   Pulaski Salo, D ^a   Dickson, D ⁱ   Robitaille, Y ^f   Bergeron, C ^g   Crain, B ^j   Benson, M D ^b,c   Farlow, M ^b   Hyman, B T ^e   St George Hyslop, P ^g   Roses, A D ^h   Pollen, D A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c Richard L Roudeboush Vet Aff M   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 14; CHROMOSOME MUTATION; FAMILIAL DISEASE; GENETIC LINKAGE; GENOTYPE; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE; SURVIVAL;

EID: 9044239670     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.406     Document Type: Article

References (70)

1. Goate A, Chartier-Harlin M, Mullan M, et al. Segregation of a missense mutation of the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
2. Naruse S, Igarashi S, Kobayashi H, et al. Missense mutation val-Ile in exon 17 of amyloid precursor gene in Japanese familial Alzheimer's disease. Lancet 1991;337:978-979.
3. Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991;254:97-99.
4. Chartier-Harlin M, Crawford F, Houlden H, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991;353:844-846.
5. Chartier-Harden MC, Crawford F, Hamandi K, et al. Screening for the beta-amyloid precursor protein mutation (APP717: Val-Ile) in extended pedigrees with early onset Alzheimer's disease. Neurosci Lett 1991;129:134-135.
6. Kennedy AM, Newman S, McCaddon A, et al. Familial Alzheimer's disease: a pedigree with a missense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-glycine). Brain 1993;116:309-324.
7. Mullan M, Crawford F, Axelman K, et al. A new mutation in APP demonstrates that pathogenic mutations for probable Alzheimer's disease frame the β-amyloid sequence. Nat Genet 1992;1:345-347.
8. Karlinsky H, Vuala G, Haines JL, et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β-amyloid precursor protein gene. Neurology 1992;42: 1445-1453.
9. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671.
10. St George-Hyslop P, Haines J, Rogaev E, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992;2:330-334.
11. Van Broeckhoven C, Backhovens H, Cruts M, et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 1992;2:335-339.
12. Mullan M, Houlden H, Windelspecht M, et al. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha-1-chymotrypsin gene. Nat Genet 1992;2:340-342.
13. Saunders AM, Strittmatter WJ, Schmechel DE, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
14. Lannfelt L, Lilius L, Appelgren, et al. No linkage to chromosome 14 in Swedish Alzheimer's disease families. Nat Genet 1993;4:218-219.
15. Struble RJ, Polinsky RJ, Hedreen JC, et al. Hippocampal lesions in dominantly inherited Alzheimer's disease. J Neuropathol Exp Neurol 1991;50:82-94.
16. Feldman RG, Chandler KA, Lewy LL, Glaser GH. Familial Alzheimer's disease. Neurology 1963;13:811-824.
17. Foncin JF, Salmon D, Supino-Viterbo V, et al. Demence presenile d'Alzheimer transmise dans une famille etendue. Rev Neurol (Paris) 1985;141:194-202.
18. Martin JJ, Gheuens J, Bruyland M, Cras P, Vandenberghe A, Masters CL. Early-onset Alzheimer's disease in two large Belgian families. Neurology 1991;41:62-68.
19. Breitner JCS, Folstein MF. Familial Alzheimer dementia: a prevalent disorder with specific clinical features. Psychol Med 1984;14:63-80.
20. Faden AI, Townsend JJ. Myoclonus in Alzheimer's disease: a confusing sign. Arch Neurol 1976;33:278-280.
21. Folstein MF, Breitner JC. Language disorder predicts familial Alzheimer's disease. Johns Hopkins Med J 1981;149:145-147.
22. Champion D, Brice A, Hannequin D, et al. A large pedigree with early-onset Alzheimer's disease: clinical, neuropathologic, and genetic characterization. Neurology 1995;45:80-85.
23. Ghetti B, Murrell J, Benson MD, Farlow MR. Spectrum of amyloid-β protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missense change at position 1924 of the APP gene. Brain Res 1992;571:133-139.
24. Terry RD, Peck A, De Teresa R, Schechter R, Horoupian DS. Some morphometric aspects of the brain in senile dementia of the Alzheimer's type. Ann Neurol 1981;10:184-192.
25. Ball MJ. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia: a quantitative study. Acta Neuropathol (Berl) 1977; 37:111-118.
26. Herzog AG, Kemper TL. Amygdaloid changes in aging and dementia. Arch Neurol 1980;37:625-629.
27. Bondareff W, Mountjoy CQ, Roth M. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1981;1:783-784.
28. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239.
29. Doucette R, Fisman M, Hachinski VC, Mersky H. Cell loss from the nucleus basalis of Meynert in Alzheimer's disease. Can J Neurol Sci 1986;13:435-440.
30. Hyman BT, Van Hoesen GW, Kromer BA, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:472-481.
31. McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 1991;30:156-165.
32. McKhann G, Drachman DA, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
33. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
34. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
35. Campbell SK, Switzer RC, Martin TL. Alzheimer's plaques and tangles: a controlled and enhanced silver staining method [abstract]. Soc Neurosci Abstr 1987;13:678.
36. Lippa CF, Hamos JE, Pulaski-Salo D, DeGennaro LJ, Drachman DA. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging 1992;13: 405-411.
37. Lippa CP, Smith TW, Swearer J. Alzheimer's disease and Lewy body disease: a comparative clinicopathologic study. Ann Neurol 1994;35:81-88.
38. Pro JD, Smith CH, Sumi SM. Presenile Alzheimer's disease: amyloid plaques in the cerebellum. Neurology 1980;30:820-825.
39. Nochlin D, van Belle G, Bird TD, Sumi SM. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Alzheimer Dis Assoc Disord 1993;7:212-222.
40. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994;36:368-378.
41. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw Hill, 1988.
42. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d'Etude du Polymorphisme Humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990;6:575-577.
43. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
44. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711.
45. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
46. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754.
47. Brousseau T, Legrain S, Berr C, Gourlet V, Vidai O, Amouyel P. Confirmation of the ∈4 allele of the apolipoprotein E gene as a major risk factor for late-onset Alzheimer's disease. Neurology 1994;44:342-344.
48. Peacock ML, Fink JK. ApoE allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994;44:339-341.
49. Houlden H, Crook R, Duff K, et al. Confirmation that the apolipoprotein ∈4 allele is associated with late-onset familial Alzheimer's disease. Neurodegen 1993;2:283-286.
50. Hyman BT, West HL, Rebeck GW, Lai F, Mann DMA. Neuropathological changes in Down syndrome hippocampal formation: effect of age and apolipoprotein E genotype. Arch Neurol 1995;52:373-378.
51. Hyman BT, Marzloff K, Arrigada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 1993;52:594-600.
52. Hansen LA, De Teresa R, Davies P, Terry RD. Neocortical morphology, lesion counts and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 1988; 38:48-54.
53. Lantos PL, Luther PJ, Hanger D, et al. Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett 1992;137:221-224.
54. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25.
55. Mann DMA, Yates PO, Marcyniuk B. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age-related continuum of pathologic changes. Neuropathol Appl Neurobiol 1984;10:185-207.
56. Armstrong RA, Nochlin D, Sumi SM, Alvord EC Jr. Neuropathological changes in the visual cortex in Alzheimer's disease. Neurosci Rec Commun 1990;6:163-171.
57. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid increased frequency of type 4 allele in familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
58. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
59. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.
60. West HL, Rebeck GW, Hyman BH. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer's disease. Neurosci Lett 1994;175:46-48.
61. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer disease. Nat Genet 1994;7:180-184.
62. Talbot CE, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoE ∈2. Lancet 1994;343:1432-1433.
63. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein ∈4 and gender. JAMA 1995;271:1316-1317.
64. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer's disease brain are related to apolipoprotein ∈ genotype. Exp Neurol 1994;125:163-171.
65. Haan J, Van Broeckhoven C, van Duijn CM, et al. The apolipoprotein E epsilon 4 allele does not influence the clinical expression of the amyloid precursor protein gene/codon 693 or 692 mutations. Ann Neurol 1994;36:434-437.
66. Van Broeckhoven C, Backhovens H, Cruts M, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169:179-180.
67. St George-Hyslop PH, Crapper-McLachlan D, Tsuda T, et al. Alzheimer's disease and possible gene interaction. Science 1994;263:537.
68. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
69. Rogaev EI, Sherrington R, Rogaev A, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778.
70. Levy-Lahad E, Wasc W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977.